These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 23891770

  • 1. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
    Özcetin A, Aigner A, Bakowsky U.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The gelatin sponge-chorioallantoic membrane assay.
    Ribatti D, Nico B, Vacca A, Presta M.
    Nat Protoc; 2006 Nov; 1(1):85-91. PubMed ID: 17406216
    [Abstract] [Full Text] [Related]

  • 4. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W, Jin K, Lan H, Han N, Cao F, Teng L.
    Hepatogastroenterology; 2012 Nov; 59(120):2543-7. PubMed ID: 22534543
    [Abstract] [Full Text] [Related]

  • 5. Ta1722, an anti-angiogenesis inhibitor targeted on VEGFR-2 against human hepatoma.
    Zheng L, He X, Ma W, Dai B, Zhan Y, Zhang Y.
    Biomed Pharmacother; 2012 Oct; 66(7):499-505. PubMed ID: 22854322
    [Abstract] [Full Text] [Related]

  • 6. Basis for dosing time-dependent change in the anti-tumor effect of imatinib in mice.
    Nakagawa H, Takiguchi T, Nakamura M, Furuyama A, Koyanagi S, Aramaki H, Higuchi S, Ohdo S.
    Biochem Pharmacol; 2006 Nov 15; 72(10):1237-45. PubMed ID: 16973134
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
    Jiang Z, Wu M, Miao J, Duan H, Zhang S, Chen M, Sun L, Wang Y, Zhang X, Zhu X, Zhang L.
    Int J Biochem Cell Biol; 2013 Aug 15; 45(8):1710-9. PubMed ID: 23702033
    [Abstract] [Full Text] [Related]

  • 11. HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.
    Yun SM, Jung KH, Kim SJ, Fang Z, Son MK, Yan HH, Lee H, Kim J, Shin S, Hong S, Hong SS.
    Cancer Lett; 2014 Jun 28; 348(1-2):50-60. PubMed ID: 24657654
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J, Chen Y, Wei L, Hong Z, Sferra TJ, Peng J.
    Int J Oncol; 2013 Nov 28; 43(5):1666-74. PubMed ID: 24042330
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
    Yener U, Avsar T, Akgün E, Şeker A, Bayri Y, Kılıç T.
    J Neurosurg; 2012 Oct 28; 117(4):697-704. PubMed ID: 22900848
    [Abstract] [Full Text] [Related]

  • 16. Characterization of compound 584, an Abl kinase inhibitor with lasting effects.
    Puttini M, Redaelli S, Moretti L, Brussolo S, Gunby RH, Mologni L, Marchesi E, Cleris L, Donella-Deana A, Drueckes P, Sala E, Lucchini V, Kubbutat M, Formelli F, Zambon A, Scapozza L, Gambacorti-Passerini C.
    Haematologica; 2008 May 28; 93(5):653-61. PubMed ID: 18367480
    [Abstract] [Full Text] [Related]

  • 17. Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.
    Yi EY, Jeong EJ, Song HS, Lee MS, Kang DW, Joo JH, Kwon HS, Lee SH, Park SK, Chung SG, Cho EH, Kim YJ.
    Int J Oncol; 2004 Aug 28; 25(2):365-72. PubMed ID: 15254733
    [Abstract] [Full Text] [Related]

  • 18. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X, Wang X, Ye H, Peng A, Chen L.
    Cancer Chemother Pharmacol; 2012 Sep 28; 70(3):425-37. PubMed ID: 22814678
    [Abstract] [Full Text] [Related]

  • 19. Enzymatic preparation of κ-carrageenan oligosaccharides and their anti-angiogenic activity.
    Yao Z, Wu H, Zhang S, Du Y.
    Carbohydr Polym; 2014 Jan 30; 101():359-67. PubMed ID: 24299784
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.